| Maysa Hamade, MD | |
|
1500 E Medical Center Dr, Ann Arbor, MI 48109-5000 | |
| (734) 936-4000 | |
| Not Available |
| Full Name | Maysa Hamade |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Neurology |
| Location | 1500 E Medical Center Dr, Ann Arbor, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003294844 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 4301107376 (Michigan) | Secondary |
| 2084N0400X | Psychiatry & Neurology - Neurology | 4301502807 (Michigan) | Primary |
| Entity Name | Regents Of The University Of Michigan |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205868353 PECOS PAC ID: 3779496856 Enrollment ID: O20031106000325 |
News Archive
A new app launched by The University of Nottingham is offering parents of newborn infants the chance to play a crucial role in research that could save the lives of premature babies in the developing world.
Access Health CT is reaching out to 5,784 customers who were either inaccurately enrolled in Medicaid, or who received inaccurate bills because their insurers received incorrect information from the exchange, officials say. Meanwhile, developments related to Minnesota's and Colorado's exchanges are also covered.
Today's headlines include reports about the proposed rule released Wednesday by the Obama administration allowing the government to continue to pay for a significant portion of health insurance for lawmakers and Hill staffers.
EpiCept Corporation announced today that it has entered into an exclusive commercialization agreement for Ceplene® (histamine dihydrochloride) with Meda AB, a leading international specialty pharmaceutical company based in Stockholm. Ceplene is EpiCept's novel therapy approved in the European Union with orphan drug status for the remission maintenance and prevention of relapse of patients with acute myeloid leukemia (AML) in first remission.
An original and progressive report on health information technology (HIT) vendors, their customers and patients, published online today, makes ground-breaking recommendations for new practices that target the reduction or elimination of tensions that currently mar relationships between many HIT vendors and their customers, specifically with regard to indemnity and error management of HIT systems.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Maysa Hamade, MD 3621 S State St, Ann Arbor, MI 48108-1633 Ph: (734) 647-5299 | Maysa Hamade, MD 1500 E Medical Center Dr, Ann Arbor, MI 48109-5000 Ph: (734) 936-4000 |
News Archive
A new app launched by The University of Nottingham is offering parents of newborn infants the chance to play a crucial role in research that could save the lives of premature babies in the developing world.
Access Health CT is reaching out to 5,784 customers who were either inaccurately enrolled in Medicaid, or who received inaccurate bills because their insurers received incorrect information from the exchange, officials say. Meanwhile, developments related to Minnesota's and Colorado's exchanges are also covered.
Today's headlines include reports about the proposed rule released Wednesday by the Obama administration allowing the government to continue to pay for a significant portion of health insurance for lawmakers and Hill staffers.
EpiCept Corporation announced today that it has entered into an exclusive commercialization agreement for Ceplene® (histamine dihydrochloride) with Meda AB, a leading international specialty pharmaceutical company based in Stockholm. Ceplene is EpiCept's novel therapy approved in the European Union with orphan drug status for the remission maintenance and prevention of relapse of patients with acute myeloid leukemia (AML) in first remission.
An original and progressive report on health information technology (HIT) vendors, their customers and patients, published online today, makes ground-breaking recommendations for new practices that target the reduction or elimination of tensions that currently mar relationships between many HIT vendors and their customers, specifically with regard to indemnity and error management of HIT systems.
› Verified 6 days ago
Ernesto F Figueroa, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2020 Hogback Road, Suite 19, Ann Arbor, MI 48105 Phone: 734-677-5900 | |
Dushyant G. Trivedi, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 555 William St., Suite #24c, Ann Arbor, MI 48104 Phone: 734-994-1171 Fax: 734-712-5745 | |
Dr. Edwin Seymour Tobes, D.O. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 117 N 1st St, Suite 103, Ann Arbor, MI 48104 Phone: 734-649-4623 | |
Dr. Joyce Danielski Kales, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2215 Fuller Rd, Ann Arbor, MI 48105 Phone: 734-769-7100 Fax: 734-769-7091 | |
Dr. Louis William Feurino Iii, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 900 Victors Way 240, Ann Arbor, MI 48108 Phone: 313-605-5330 Fax: 734-661-0322 | |
Benjamin Martin Bly, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1500 East Medical Center Drive, 1st Floor University Hospital Room 1b300, Ann Arbor, MI 48109 Phone: 734-936-9035 Fax: 734-936-5520 | |
Hao Cheng, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 425-502-5290 |